<section id ="1155120-1171684" class="mfp-hide modal-dialog modal-content overlay-def"><header class="modal-header"><h2 class="modal-title">2019, c. 29, s. 17</h2></header><div class="modal-body"><ul class="Section ProvisionList" id="1155120"><li><p class="Subsection amending" id="1155121"><strong><a class="sectionLabel" id="s-17"><span class="sectionLabel">17</span></a></strong> <span class="lawlabel">(1)</span> Paragraph 118.2(2)(u) of the Act is replaced by the following:</p><section><div class="AmendedText"><ul class="ProvisionList"><li><p class="Paragraph"><span class="lawlabel">(u)</span> on behalf of the patient who is the holder of a <span class="DefinitionRef"><dfn>medical document</dfn></span> (as defined in subsection 264(1) of the <cite class="XRefExternalRegulation">Cannabis Regulations</cite>) to support their use of cannabis for medical purposes, for the cost of cannabis, cannabis oil, cannabis plant seeds or cannabis products purchased for medical purposes from a holder of a <span class="DefinitionRef"><dfn>licence for sale</dfn></span> (as defined in subsection 264(1) of the <cite class="XRefExternalRegulation">Cannabis Regulations</cite>).</p></li></ul></div></section></li><li><p class="Subsection CIF" id="1155123"><span class="lawlabel">(2)</span> Subsection (1) is deemed to have come into force on October 17, 2018.</p></li></ul></div></section>